Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2011 Apr 28;3(2):2223–2242. doi: 10.3390/cancers3022223

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2011 by the authors; licensee MDPI, Basel, Switzerland.

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

PMC Copyright notice

Figure 4. — Serum levels of anti-KLH antibody relative to treatment sequence. Representative data from patients with cancer of the (A) breast; (B) ovary; (C) stomach; and (D) lung. Anti-KLH assessed by ELISA in serum samples obtained before and after treatment. KLH administration occurred at timepoint 0 and is denoted by K*; R indicates the time at which the immunization sites were irradiated. Significant increases in anti-KLH antibody levels following treatment are indicated by double (p < 0.005) and single (p < 0.05) star.